Protein-protein interactions can be regulated by protein modifications such as phosphorylation. Some of the phosphorylation sites (Ser 155 , Ser 162 and Ser 170 ) of HBV (hepatitis B virus) Cp have been discovered and these sites are implicated in the regulation of viral genome encapsidation, capsid localization and nucleocapsid maturation. In the present report, the dimeric form of HBV Cp was phosphorylated by PKA (protein kinase A), but not by protein kinase C in vitro, and the phosphorylation of dimeric Cp facilitated HBV core assembly. Matrix-assisted laser-desorption ionization-time-of-flight analysis revealed that the HBV Cp was phosphorylated at Ser 87 by PKA. This was further confirmed using a mutant HBV Cp with S87G mutation. The S87G mutation inhibited the phosphorylation and, as a result, the in vitro HBV core assembly was not facilitated by PKA. In addition, when either pCMV/FLAG-Core(WT) or pCMV/FLAG-Core(S87G) was transfected into HepG2 cells, few mutant Cps (S87G) assembled into capsids compared with the wild-type (WT) Cps, although the same level of total Cps was expressed in both cases. In conclusion, PKA facilitates HBV core assembly through phosphorylation of the HBV Cp at Ser 87 .
INTRODUCTION
Human HBV (hepatitis B virus) is a member of the Hepadnaviridae family and has infected over two billion people worldwide [1] . Acute infections can result in serious illness, and chronic HBV infection causes liver diseases such as liver cirrhosis and hepatocellular carcinoma as well as other serious consequences [2] . HBV is currently classified into eight genotypes, A-H, on the basis of full-length genome sequencing. Variations in the viral infectivity and replication level are due to the genomic differences between the different genotypes [3] [4] [5] .
HBV has a partially double-stranded DNA genome comprising four ORFs (open reading frames), denoted C, S, P, and X [6, 7] . The C ORF encodes the HBV Cp (core protein), which plays an essential role in the life cycle of the virus. pgRNA (pregenomic RNA), HBV polymerase and other components such as heat shock proteins and protein kinases are packaged into the capsid, which is an assembled form of the Cp, and viral replication is able to commence.
HBV Cp is 183-185 amino acids long, consisting of an N-terminal assembly domain (amino acids 1-149) and a Cterminal protamine domain (amino acids 150-183 or 185) [8] . The N-terminal assembly domain is related to the HBV core assembly, while the C-terminal protamine domain is known for the regulation of viral replication [9] . The capsid comprises 90 (T = 3 form) or 120 (T = 4 form) Cp dimers [10] . The first step of HBV core assembly is the formation of dimeric forms of the Cp subunit from its monomers; a trimer of dimers then nucleates capsid assembly, followed by rapid addition of subsequent dimers [8] . Generally, Cp149, a 34-residue truncated form of the Cterminal domain of the HBV Cp, spontaneously forms a capsid under suitable conditions in vitro and in vivo [11, 12] . This protein has been used for the study of core assembly because it can be overexpressed in Escherichia coli and is structurally similar to the HBV core antigen [10, 13] .
The process of HBV core assembly is related to the specific encapsidation of the pgRNA-polymerase complex mediated by HBV Cp phosphorylation [14, 15] . Several kinases such as cdc2 kinase, PKA (protein kinase A), PKC (protein kinase C), 46 kDa serine kinase, SRPK1 (serine/arginine protein-specific kinase 1), and SRPK2 have been found to phosphorylate the HBV Cp [16] [17] [18] [19] 259 in duck hepatitis B virus) have been identified using these kinases and these sites were found to be related to the encapsidation of the pgRNA-polymerase complex, viral genome replication and capsid localization [14, 18, 20, 21] . On the other hand, the roles and the sites of phosphorylation in the N-terminal assembly domain are unclear and only a cdc2 kinase-like recognition motif (Thr 128 ) has been identified [22] . In the present study, we observed that the PKA-mediated phosphorylation of HBV Cp at Ser 87 , which is located in the N-terminal HBV Cp, facilitates the core assembly in the life cycle of HBV by increasing the affinity between HBV Cp dimers.
MATERIALS AND METHODS

Plasmids
A mutant Cp with S87G mutation was constructed using the forward primer 5 -TTAGTAGTCGGCTATGTCA-3 , the reverse primer 5 -TGACATAGCCGACTACTAA-3 and pHBV1.2x as a template. The construct of pHBV1.2x genotype C was described previously [23] . The mutation was confirmed by nucleotide sequencing. To express the mutant Cp149(S87G) in E. coli, the Abbreviations used: Cp, core protein; FC, flow cell; HBV, hepatitis B virus; MALDI-TOF, matrix-assisted laser-desorption ionization-time-of-flight; ORF, open reading frame; PKA, protein kinase A; PKC, protein kinase C; pgRNA, pregenomic RNA; RU, response unit; SPR, surface plasmon resonance; SRPK1, serine/arginine protein-specific kinase 1; TEM, transmission electron microscopy; WT, wild-type; WT PKA, PKA-treated wild-type. 1 To whom correspondence should be addressed (email drjung@snu.ac.kr).
mutant Cp was constructed as described in [24] . The WT (wildtype) and mutant pCMV/FLAG-Core were constructed by fusing the FLAG-tag to pCMV-Core as described previously [23] .
Cp149 protein expression and purification
The Cp149(S87G) mutant was cloned into the pET28b vector (Novagen, Madison, WI, U.S.A.) then transformed into BL21 (DE3) + pLysS E. coli (Novagen) and purified as described previously [24] . The assembly of mutant Cp149(S87G) was confirmed by native gel electrophoresis and Western blotting.
Detection of PKA-mediated core phosphorylation and assembly
For the experiments, 20 µM of purified dimeric Cp149 was incubated with reaction buffer (10 mM Hepes, pH 7.5 and 10 mM MgCl 2 ), 10 µM ATP and 1 unit of PKA (Sigma, St. Louis, MO, U.S.A.). For the inhibition experiment, serially diluted H-89 (1, 5 or 10 µM; PKA specific inhibitor; Sigma) was used. Samples were incubated at 30
• C for the designated times. After stopping the reaction with 50 mM EDTA, each sample was separated by electrophoresis on a 0.9 % native gel, followed by Western blot analysis with anti-HBc antibody (DAKO, Glostrup, Denmark) as described previously [23] . To detect the phosphorylation of Cp149, 10 µM of [γ -
32 P]ATP (3000 Ci/mmol) was used instead of unlabelled ATP. PKC (1 unit; Promega, Madison, WI, U.S.A.) was used for the control experiment. The band intensities were analysed using ImageMaster 2D Elite software 4.01 (Amersham Pharmacia Biotechnology, Uppsala, Sweden).
Determination of binding affinity of proteins using SPR (surface plasmon resonance)
The analysis was performed using a BIAcore 3000 instrument (Biacore AB, Uppsala, Sweden). The samples (Cp149 treated with PKA or not treated) were denatured with 3.5 M urea and fractionated for the purification of Cp149 dimers as described previously [24] . FC1 (flow cell 1) was a negative control (without any proteins), while in the experimental flow cells, WT (FC2) and PKA-treated WT dimeric Cp149 (FC3) were immobilized according to the manufacturer's instructions. Results, measured as RUs (response units) were obtained with change of sensorgrams from FC2 and FC3 compared with FC1 for 100 s to detect the association rate or for 150 s to detect the dissociation rate. The temperature of the flow cell was maintained at 30
• C. To determine the binding affinity of immobilized Cp149, five concentrations of Cp149 dimer (10, 5, 2.5, 1.25, and 0.625 µM) were injected over the biosensor surface at a flow rate of 60 µl/min and the sensor chip was regenerated with 50 mM NaOH. Data were analysed with the BIAevaluation software version 3.1 (Biacore AB).
Electron microscopy and sucrose step gradient analysis
In vitro Cp149 assembly by PKA was performed as described above. Electron microscopy and sucrose step gradient analysis were carried out as described previously [24] , except for the composition of the buffer (10 mM Hepes, pH 7.5 and 10 mM MgCl 2 ).
Detection of cytoplasmic HBV capsid in transfected cells
HepG2 cells were maintained in Dulbecco's modified Eagle's medium (Sigma) with 10 % (v/v) foetal bovine serum (GIBCO ® , Grand Island, NY, U.S.A.). Cells were seeded in 100 mm diameter dishes and were transfected the following day with the appropriate DNA and FuGENE TM 6 (Roche) as described by the manufacturer. For the control experiment, pRc/CMV (Invitrogen, Carlsbad, CA, U.S.A.), the backbone DNA of pCMV/FLAG-Core(WT) and pCMV/FLAG-Core(S87G) were used. After transfection, the cells were cultured for 2 days and harvested. The assembled HBV Cps in the lysate were separated by sucrose step gradient analysis and detected as described previously [23] ; the sucrose step gradient buffer was composed of 10 mM Hepes, pH 7.5.
Tryptic in-gel digestion and MALDI-TOF (matrix-assisted laser-desorption ionization-time-of-flight)-MS
Protein bands were excised from an SDS/15 % PAGE gel and in-gel digestion was performed as described previously [25] . Mass spectra were obtained using the MALDI-TOF-TOF 4700 tandem mass spectrometer (Applied Biosystems, CA, U.S.A.). The peptide digest was mixed with a matrix and the mixture was applied to a stainless steel plate. To analyse the peptide mass peak, Data Explorer TM software (Applied Biosystems) was used.
RESULTS
Phosphorylation of HBV Cp by PKA facilitates core assembly
To investigate the effect of PKA on HBV core assembly, the assembled Cp level was estimated by native gel electrophoresis and sucrose step gradient analysis, which have been widely used for detecting the capsid form of HBV Cp [26, 27] .
An in vitro kinase assay was performed with and without 1 unit of PKA (Sigma) at 30
• C for 30 min. Samples were separated using native gel electrophoresis to detect the assembled Cp and the phosphorylation of capsid particle. The assembled Cp149 was phosphorylated by PKA ( Figure 1B, lane 3) . The assembled Cp level in the presence of PKA ( Figure 1A , lane 3) increased 2.5-fold compared with the WT Cp without PKA ( Figure 1A , lane 2). To determine whether the Cp was specifically phosphorylated by PKA, an in vitro kinase assay was carried out using the PKA-specific inhibitor H-89 (Sigma). Cp149 was incubated with serially diluted H-89 (1, 5 or 10 µM) and 1 unit of PKA. The phosphorylation of the assembled Cps was decreased by H-89 ( Figure 1B, lanes 4-6) and the level of assembled Cp149 was also reduced ( Figure 1A, lanes 4-6) . The results show that core phosphorylation and assembly mediated by PKA were inhibited by H-89 in a concentration-dependent manner. On the other hand, PKC neither phosphorylated Cp149 nor affected the assembled Cp level ( Figures 1A and B, lanes 8) .
To confirm the PKA-mediated increase in HBV core assembly, the time course of the assembled Cp level was assessed. The intensity of the PKA-untreated Cp149 band at 1 min (Figure 2A , middle panel, lane 1) was set as the standard and the relative intensities of the other bands were analysed (Figure 2A, bottom  panel) . The time course evaluation indicated that the level of assembled PKA-treated WT Cp149 (Figure 2A, top panel) increased at a faster rate compared with that of assembled WT Cp149 without PKA treatment (Figure 2A, middle panel) . Sucrose step gradient analysis was also used to confirm the increase in assembled Cp149 by PKA-mediated phosphorylation. The samples were incubated at 30
• C for 1 h without or in the presence of PKA. The samples were fractionated from top to bottom. The dimeric Cp149 and assembled Cp149 were located at the top and middle layers of the sucrose gradient respectively ( Figure 2B ; fraction number, 1-3 and 6-7 respectively). When PKA was incubated with the reaction mixture, the amount of dimeric Cp149, as indicated by the density of individual bands, was reduced and more assembled Cp149 was formed ( Figure 2B ). These results show that in contrast to PKC, PKA phosphorylates the N-terminal domain (amino acids 1-149) of the WT Cp and increases the assembled Cp level. Table 1 . *1000 RU = change of mass by 1 ng/mm 2 .
Comparison of Cp149 protein-protein interactions using the SPR technique
HBV capsid formation starts with the interactions of dimeric Cps. Therefore, to investigate the cause of enhanced in vitro core assembly due to PKA, SPR was used to assess the binding affinity between Cp149 dimers. Samples were prepared as described in the Materials and methods section and the analysis was performed using a BIAcore 3000 instrument (Biacore AB). Sensorgrams of the interaction between dimeric Cp149 are shown in Figure 3 and detailed accounts of the kinetics of the interactions between 1 and 2 ), the increase in k a (10-fold) is the main factor that causes the reduction in K D (14-fold), whereas no significant decrease in k d is observed (1.3-fold) . This data suggests that the increased affinity between WT Cp149 dimers, as a result of phosphorylation, is mainly due to the elevated rate of dimeric Cp149 association (Figure 3, compare A with B) . Furthermore, the K D of No. 3 (2.6 × 10 −7 M) decreased 49-fold when compared with that of No. 1 (1.3 × 10 −5 M). This data indicates that dimers combine more rapidly when both the combining Cp dimers are phosphorylated by PKA than when only one of the Cp dimers is phosphorylated. As a result, PKA-mediated phosphorylation may elevate the rate of intermediate formation and the subsequent addition of dimeric Cps, resulting in a marked effect on the rate of capsid formation.
Identification of core phosphorylation sites using MALDI-TOF-MS
MALDI-TOF-MS was used to identify the PKA phosphorylation site(s) in Cp149. Cp149 protein expressed in E. coli was treated with PKA or untreated. The dimeric WT Cp149 ( Figure 4A ) and PKA-treated WT Cp149 ( Figure 4B ) were separated by SDS/PAGE (15 % gel) and analysed by MALDI-TOF-MS. The spectrum showed a peak at 1644.7 m/z ( Figure 4B ) that corresponded to the theoretical m/z of the core peptide comprising 83-96 amino acids (1564.8 m/z) and a single phosphate. There are two possible phosphorylation sites within the core peptide of 83-96 amino acids: Ser 87 and Tyr 88 . However, since PKA phosphorylates serine/threonine and the peak did not shift from 1564.8 m/z to 1724.7 m/z (results not shown), which would correspond to two phosphate molecules, Ser 87 was selected as the putative PKA phosphorylation site.
Comparison of the levels of in vitro-assembled WT and mutant Cps
Mutant Cp149 (S87G) was constructed and purified in E. coli as described in the Materials and methods section. To study the effect of the S87G mutation on in vitro assembly, the assembly reaction was performed with the same amounts (20 µM) of dimeric WT and mutant Cp149. Despite the amino acid change at Ser 87 , WT and mutant Cp149 revealed almost the same level of core assembly in the absence of PKA in vitro ( Figure 5 , top panel, 1 and 3) . When WT and mutant Cp149 were incubated with PKA, the level of assembled WT Cp149 increased ( Figure 5 , top panel, lane 2), whereas that of assembled mutant Cp149 did not ( Figure 5, top panel, lane 4) . As shown in Figure 5 bottom panel, the phosphorylation of WT Cp149 (lane 2) was detected using [γ -
32 P]ATP and the S87G mutation inhibited the phosphorylation of mutant Cp149 (lane 4). This result suggested that Ser 87 of Cp149 is the unique PKA phosphorylation site, which is in agreement with the result obtained from the MALDI-TOF-MS analysis.
Measurements of assembled Cp149 using TEM (transmission electron microscopy)
To identify whether phosphorylation and mutation of Cp149 affect capsid formation, the in vitro assembled core particles were negatively stained and observed by TEM. The diameter of WT Cp149 was determined to be approximately 30 nm (T = 4 form) [29] . From the TEM data, the approximate diameters of the WT Cp149 capsid ( Figure 6A ) and the PKA-treated core particle ( Figure 6B ) were estimated to be 30 nm (average diameters of 30.27 and 30.38 nm respectively). In addition, the approximate diameter of mutant Cp149 (S87G) ( Figure 6C ) was also estimated to be 30 nm (with an average diameter of 30.25 nm). The shapes of these in vitro assembled Cps were also identical ( Figure 6A , B and C). From these results, the PKA-treated WT core particles and mutant core particles were considered to be identical with the WT Cp149 particles with regard to their morphology.
Comparison of the core assembly between WT and mutant Cps in HepG2 cells
To identify the effect of phosphorylation on in vivo core assembly, FLAG-tagged WT and mutant (S87G) Cps were transfected into HepG2 cells. Cell lysates from each sample were resolved by SDS/PAGE (15 % gels) and Western blot analysis with anti-FLAG antibody (Sigma) was performed to detect the total expressed Cp. The assembled Cps in HepG2 cells were separated by native agarose gel electrophoresis, and Western blot analysis with antiHBc antibody was carried out for their detection. The results of the Western blots were quantified as described previously [23] . The amount of WT capsid protein (Figure 7 , middle panel, lane 2) 
Figure 7 Comparison of WT and mutant Cps in HepG2 cells
To detect cytoplasmic HBV Cp, the HepG2 cells were transfected with pCMV/FLAG-Core(WT) (lane 2) and pCMV/FLAG-Core(S87G) (lane 3). Backbone DNA (pRc/CMV) was transfected as a control (lane 1). Total Cps were separated by SDS/PAGE (15 % gel; top panel) and detected by Western blotting with anti-FLAG antibody. The assembled Cps were separated on 0.9 % native agarose gel (middle panel) and detected by Western blotting with anti-HBc antibody. The band intensities were normalized to the intensity of the pCMV/FLAG-Core(S87G) band, which was set as the standard (bottom panel). increased 2.5-fold in comparison with the mutant capsid protein (Figure 7, middle panel, lane 3) , although the same level of total Cp was expressed in both cases (Figure 7, top panel, lanes 2 and 3) . The backbone DNA that was used as a control did not express Cp in HepG2 cells (Figure 7, top panel, lane 1) . These results suggest that the phosphorylation of Cp at Ser 87 elevated the level of in vivo core assembly.
DISCUSSION
The regulation of pgRNA encapsidation and viral replication by several kinases has been investigated mainly through the phosphorylation of the C-terminal domain of HBV Cp. However, in the present report, we have investigated the PKA-mediated phosphorylation of the N-terminal domain of the HBV Cp and the increased HBV core assembly by in vitro phosphorylation. SPR was used to investigate the factors that cause increased core assembly, which revealed that increased core assembly was due mainly to the elevated rate of dimeric Cp149 association as a result of PKA-mediated phosphorylation. Using MALDI-TOF-MS, Ser 87 of the Cp was identified as the specific PKA phosphorylation site, and the PKA-mediated increase in core assembly was inhibited by replacing Ser 87 with glycine in vitro. When WT and mutant (S87G) genes were transfected into HepG2 cells, the mutant Cp also showed a lower assembly compared with the WT Cp.
Ser 87 is present in the fourth α-helix structure of the Cp, which is far from important residues (namely, amino acids 113-143) involved in the interactions between dimers [30] . However, previous reports have indicated that core assembly is facilitated by naturally occurring F97L mutation in the fourth α-helix of HBV Cp [13] , and that cations such as Zn 2+ , Ca 2+ and Na + also facilitate core assembly [24, 28, 31] by altering protein conformation. It has been shown that PKA causes conformational changes in proteins [32] . Therefore the increase in HBV core assembly may be due to the conformational change induced by PKA-mediated phosphorylation of HBV Cp at Ser 87 . In the early stages of viral infection, a high level of serum HBV DNA is detected [33] . Subsequently, patients enter the chronic phase that is accompanied by changes in the amino acids of the immunological epitope of the HBV Cp due to immune pressure; the patients show decreased serum HBV DNA level [33] [34] [35] . The fourth α-helix structure of the Cp is an immunological epitope for B and T cells, which is highly mutated in chronic HBVinfected patients. Ser 87 is also mutated in the chronic phase and is predominantly substituted with glycine [33, [35] [36] [37] [38] . Our results suggest that the in vitro PKA-mediated phosphorylation of HBV Cp at Ser 87 facilitated core assembly. However, S87G mutation inhibited the PKA-mediated phosphorylation of the HBV Cp and caused reduction in the assembled Cp level. Since HBV core assembly is followed by viral replication, S87G mutation may cause a decrease in the serum HBV DNA level in the chronic phase through impaired core assembly.
In HBV core assembly, a trimer of dimeric Cp nucleates capsid assembly and at least 0.7-0.8 µM of dimeric Cp is required for capsid formation [8, 39] . Using SPR, the association value of PKA-phosphorylated Cp149 dimers was estimated to be approx. 40 RU, whereas that of unphosphorylated Cp149 dimers was less than 6 RU. This was observed at a dimeric Cp149 concentration of 0.625 µM, which is lower than that required for core assembly. This data supported the fact that increased affinity of phosphorylated dimers may facilitate the formation of the core nucleus, although the concentration of HBV Cp may not be sufficient for capsid assembly.
On the basis of the results of this study, we suggest that PKA is a new factor that facilitates the HBV core assembly via the phosphorylation of the HBV Cp. The PKA-mediated phosphorylation of the dimeric Cp at Ser 87 increases the affinity between Cp dimers and facilitates HBV core assembly both in vitro and in vivo. Since HBV core assembly is followed by viral replication, our results will be useful in understanding the regulation of viral replication through the phosphorylation of the HBV Cp. 
